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Sensory neurons are important in controlling cutaneous inflammation, but the role of neurons in host antimi-
crobial defense was relatively unknown. Kaplan and colleagues now demonstrate that nociceptive fibers
within the dermis play a crucial role in antifungal defenses through their influence on dermal dendritic cells
and induction of IL-17A.Mammalian skin is a densely innervated
organ, but a clear and direct link between
these sensory fibers and the cutaneous
immune network has only recently been
described. Notably, nerve fibers within
the skin can play an essential role in main-
taining inflammation since local denerva-
tion has been observed to result in a dra-
matic improvement in mouse models of
psoriasis-like skin inflammation (Ostrow-
ski et al., 2011). The mechanisms behind
this observation were partially explained
with the discovery that nociceptor sen-
sory neurons induce IL-23 expression
from dermal dendritic cells (dDCs). These
dDCs in turn activate skin-resident gd
T cells to produce IL-17A, a major driver
of psoriasiform inflammation (Riol-Blanco
et al., 2014). These findings were further
supported by clinical observations in
humans that psoriatic plaques improve
following local nerve damage. What re-
mained unknown, however, was whether
antimicrobial functions of the cutaneous
innate immune response could be directly
linked to the skin sensory nervous
system.
An increasing body of evidence sup-
ports the conclusion that nerves can
sense microbes. For example, it has
been demonstrated that nerve fibers
can directly sense bacteria via various
membrane-bound receptors (Chiu et al.,
2013; Meseguer et al., 2014). Activation
of these fibers occurs before the onset
of clinical inflammation, suggesting that
sensory effects associated with bacterial
infections are the result of direct micro-
bial stimulation of neurons rather than a
downstream effect of inflammatory pro-
cesses. Indeed, in vitro and in vivomodels
have illustrated that bacteria and bacterial
products result in rapid sensory re-
sponses including the induction of pain,
vasodilation, and neuropeptide release414 Immunity 43, September 15, 2015 ª2015(Chiu et al., 2013; Meseguer et al., 2014).
Thus, it is becoming increasingly clear
that the peripheral nervous system is
capable of detecting the microbiome,
and as a consequence it is in a position
to influence innate immune processes
present in the skin and other organs.
Kaplan and colleagues expand on this
growing body of literature and demon-
strate in this issue of Immunity that cuta-
neous sensory neurons can recognize
Candida albicans and initiate IL-17-
mediated protective immune responses
(Figure 1) (Kashem et al., 2015). The au-
thors show that neurons activate the
CD301b+ subset of dDCs to produce IL-
23 that then drives IL-17A production
from skin-resident gd T cells. This study
supports the concept that microbes are
capable of directly stimulating neurons.
Furthermore, the authors show that expo-
sure to Candida albicans results in
increased release of the neuropeptide
CGRP, and that this is sufficient and
necessary to induce IL-23 expression in
dDCs. The study also identifies the spe-
cific DC subset (CD310b+) that produces
IL-23 and determines that gd T cells,
rather than Th17 cells or other cell types,
are the predominant IL-17 producers.
Deficiencies in any step of this
pathway—neuronal activation and CGRP
release, IL-23 production from dDCs,
or IL-17A release from gd T cells—results
in a defective immune response and
increased fungal burdens.
Th17 responses and the production of
IL-17 family cytokines have a well-estab-
lished role in cutaneous protection
against numerous pathogenic microbes,
including bacteria, fungi, and viruses. In
particular, protection from chronic muco-
cutaneous candidiasis (CMC) seems to
be strongly mediated by IL-17, as patients
with a variety of conditions impairing Th17Elsevier Inc.cell development and function show
increased susceptibility to infection with
this microbe (McDonald, 2012). In addi-
tion to classical Th17 cells, innate sources
of IL-17 production in the skin have
been identified, notably various classes
of gd T cells including dendritic epidermal
T cells (DETCs) (Gray et al., 2011;
MacLeod et al., 2013). DETC-derived IL-
17A plays an important role in the regula-
tion of skin defenses and wound healing.
This appears to be mediated in part
through actions to induce antimicrobial
peptide (AMP) production from epidermal
keratinocytes (MacLeod et al., 2013).
Although the present article from Kaplan
and colleagues does not elucidate the
mechanisms behind IL-17A-mediated
killing of C. albicans, it is likely that AMP
production and recruitment of phagocytic
effectors to the site of infection are part
of the processes involved in pathogen
clearance.
Although the exact influences of sen-
sory neurons on cutaneous immunity are
still being elucidated, interesting informa-
tion has arisen illustrating both beneficial
and detrimental effects of their activation.
On one hand, unwarranted inflammation
driving the disease psoriasis appears to
be worsened by neuropeptide release.
This detrimental effect of neuron activa-
tion is illustrated by the observations
that ablation of sensory neurons alleviates
psoriatic inflammation (Ostrowski et al.,
2011; Riol-Blanco et al., 2014). However,
the problem with immune-dampening
effects of neural ablation is illustrated in
the data presented by Kaplan and col-
leagues as an attempt to treat disease
by blocking nociceptive fibers predicts
that this will leave the host more suscepti-
ble to infection with C. albicans (Kashem
et al., 2015). Interestingly, activation
of sensory neurons by Staphylococcus
Figure 1. Candida albicans Stimulate IL-17A Production through Sensory Neuron Activation
Cutaneous nociceptor sensory neurons detect invading Candida albicans, resulting in the release of the
neuropeptide calcitonin gene-related peptide (CGRP). CGRP stimulates CD301b+ dermal dendritic cells
(dDCs) to produce IL-23, which in turn activates skin-resident gd T cells to secrete IL-17A, an important
cytokine mediating antifungal defenses in the skin. AMPs, antimicrobial peptides.
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Previewsaureus was demonstrated to exert
immunosuppressive effects, as in this
study neural ablation abrogated the pain
response but led to increased cytokine
production and inflammation (Chiu et al.,
2013). This work did not investigate levels
of gd T cell-derived IL-17A, which has
also been shown to be important in the
innate immune response to S. aureus
(Cho et al., 2010). It is interesting to
consider that the context of the interac-
tion between neural cells, immune cells,
and microbes will be critical to predicting
outcome. Certain pathogens might have
evolved to utilize neural activation as a
virulence factor or method to establish
growth over other microbes. S. aureus
pathogenesis might be enhanced by
neural activation, whereas survival of
C. albicans appears to be negatively
impacted by these processes. In fact,
co-infections with S. aureus and
C. albicans are uncommon in immuno-
competent patients.
It is well documented that psychologi-
cal stress also has a negative impact on
cutaneous immunity, as skin infections
are more frequent and healing is delayedduring prolonged periods of stress. Stress
signals activate neuroendocrine circuits
that result in decreased AMP production,
leaving the skin more vulnerable to bacte-
rial infections (Radek et al., 2010). Neuro-
endocrine circuits are distinct from the
nociceptive fibers described in the current
work. However, stimulation of different
neural components of the skin might
result in divergent effects on the immune
system, thereby increasing or decreasing
innate antimicrobial defenses.
An interesting question to be ad-
dressed in future work involves the under-
lying molecular aspects for C. albicans
recognition by sensory neurons. Bacteria
are detected by and activate these
nerve fibers through a variety of mecha-
nisms, including formyl peptide receptors
(FPRs), LPS activation of Toll-like recep-
tor 4 (TLR4) and the cation channel
TRPA1, and direct perforation of cell
membranes by pore-forming toxins.
Meanwhile, it is known that immune cells
sense C. albicans via TLR2 and dectin-1,
but the expression of these receptors on
sensory neurons has yet to be shown. It
will be important to uncover the interac-Immunity 43, Setions between C. albicans and sensory
neurons and determine whether different
morphological forms or strains with vary-
ing virulence display altered ability to
stimulate nociceptive fibers in the skin.
In conclusion, Kaplan and colleagues
have contributed important new informa-
tion to the growing body of evidence illus-
trating a complex neural-cutaneous im-
mune axis, showing for the first time that
a fungal pathogen activates sensory fi-
bers to initiate an effective antimicrobial
response (Kashemet al., 2015). These ob-
servations, and other data that have
shown direct links between the nervous
system and the immune system, demon-
strate that in the skin the production of
IL-17A has quite some nerve!REFERENCES
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